Internal Medicine · Anaheim, CA
NPI
1083883904
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1751 W Romneya Dr Ste H
Anaheim, CA, 92801
Phone (714) 563-2114
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
622 services
Medicare patients, 2024
87
Average age 78
Drug cost, 2024
$1.2M
14,111 prescriptions
Company payments, 2025
$349
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Corazon C Medina was code 99213 (office e&m - established), 221 times for 84 patients. In total Corazon C Medina billed 622 services in 16 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 221 | 84 | $72.35 | $16K |
| 36415 Venipuncture Blood Collection | Office | 57 | 36 | $8.65 | $493 |
| 85025 Blood Count | Office | 55 | 36 | $7.61 | $419 |
| 84443 Clinical Chemistry | Office | 53 | 34 | $16.46 | $872 |
| 80053 Clinical Chemistry | Office | 48 | 35 | $10.35 | $497 |
| 84439 Clinical Chemistry | Office | 46 | 33 | $8.84 | $407 |
| 80061 Clinical Chemistry | Office | 45 | 33 | $13.12 | $590 |
| 83735 Clinical Chemistry | Office | 39 | 27 | $6.57 | $256 |
| 83036 Blood Count | Office | 31 | 22 | $9.52 | $295 |
| 99214 Office E&M - Established | Office | 12 | 11 | $93.43 | $1,121 |
By year: 2022 $22K for 670 services; 2023 $21K for 653 services; 2024 $22K for 622 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 57 | 36 | $8.65 | $493 |
| 85025 Blood Count | 55 | 36 | $7.61 | $419 |
| 84443 Clinical Chemistry | 53 | 34 | $16.46 | $872 |
| 80053 Clinical Chemistry | 48 | 35 | $10.35 | $497 |
| 84439 Clinical Chemistry | 46 | 33 | $8.84 | $407 |
| 80061 Clinical Chemistry | 45 | 33 | $13.12 | $590 |
| 83735 Clinical Chemistry | 39 | 27 | $6.57 | $256 |
| 83036 Blood Count | 31 | 22 | $9.52 | $295 |
Medicare prescription drug claims, 2024
In 2024, the drug Corazon C Medina prescribed most often to Medicare patients was Amlodipine Besylate, with 903 prescriptions and refills. In total Corazon C Medina wrote 14,111 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 903 | 2,493 | 249 | $4,337 |
| Atorvastatin Calcium Generic | 885 | 2,386 | 246 | $7,511 |
| Metformin Hcl Generic | 769 | 2,120 | 224 | $5,050 |
| Losartan Potassium Generic | 756 | 2,104 | 207 | $7,601 |
| Rosuvastatin Calcium Generic | 398 | 1,124 | 119 | $5,181 |
| Levothyroxine Sodium Generic | 359 | 984 | 99 | $5,041 |
| Alendronate Sodium Generic | 290 | 716 | 81 | $2,273 |
| Omeprazole Generic | 289 | 718 | 90 | $2,686 |
| Simvastatin Generic | 277 | 796 | 78 | $2,378 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 247 | 337 | 87 | $6,560 |
| Gabapentin Generic | 243 | 495 | 70 | $2,736 |
| Meloxicam Generic | 201 | 248 | 62 | $531 |
| Azithromycin Generic | 195 | 195 | 149 | $491 |
| Lisinopril Generic | 193 | 568 | 58 | $1,309 |
| Pantoprazole Sodium Generic | 191 | 483 | 63 | $1,985 |
Brand drugs: 1,686 claims; generic drugs: 12,116 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Corazon C Medina $349 ($349 in general payments such as food, travel and fees) from 4 companies. The largest payer was Kowa Pharmaceuticals America, Inc. with $164.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.